174 related articles for article (PubMed ID: 28586047)
21. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Xia P; Li Q; Wu G; Huang Y
J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
[TBL] [Abstract][Full Text] [Related]
22. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL
J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692
[TBL] [Abstract][Full Text] [Related]
23. Identification and functional analysis of risk-related microRNAs for the prognosis of patients with bladder urothelial carcinoma.
Gao J; Li H; Liu L; Song L; Lv Y; Han Y
Oncol Lett; 2017 Dec; 14(6):7297-7303. PubMed ID: 29344166
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.
Li Y; Xu J; Chen H; Bai J; Li S; Zhao Z; Shao T; Jiang T; Ren H; Kang C; Li X
Nucleic Acids Res; 2013 Dec; 41(22):e203. PubMed ID: 24194606
[TBL] [Abstract][Full Text] [Related]
25. Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.
Liu Z; Meng H; Fang M; Guo W
J Healthc Eng; 2021; 2021():3251891. PubMed ID: 34845420
[TBL] [Abstract][Full Text] [Related]
26. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
[TBL] [Abstract][Full Text] [Related]
27. Prognostic power of a lipid metabolism gene panel for diffuse gliomas.
Wu F; Zhao Z; Chai RC; Liu YQ; Li GZ; Jiang HY; Jiang T
J Cell Mol Med; 2019 Nov; 23(11):7741-7748. PubMed ID: 31475440
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
29. Methylation of the miR-126 gene associated with glioma progression.
Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
[TBL] [Abstract][Full Text] [Related]
31. Integrated mRNAseq and microRNAseq data analysis for grade III gliomas.
Dai J; Bing Z; Zhang Y; Li Q; Niu L; Liang W; Yuan G; Duan L; Yin H; Pan Y
Mol Med Rep; 2017 Nov; 16(5):7468-7478. PubMed ID: 28944855
[TBL] [Abstract][Full Text] [Related]
32. MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.
Qian J; Li R; Wang YY; Shi Y; Luan WK; Tao T; Zhang JX; Xu YC; You YP
Mol Cell Biochem; 2015 May; 403(1-2):33-41. PubMed ID: 25648114
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
34. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
Su X; Li H; Chen S; Qin C
Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
[TBL] [Abstract][Full Text] [Related]
35. Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression.
Zhang Y; Xu Y; Li F; Li X; Feng L; Shi X; Wang L; Li X
Oncotarget; 2016 May; 7(18):25769-82. PubMed ID: 27013589
[TBL] [Abstract][Full Text] [Related]
36. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
37. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
[TBL] [Abstract][Full Text] [Related]
38. Analysis of gene profiles in glioma cells identifies potential genes, miRNAs, and target sites of migratory cells.
Xue F; Shen R; Chen X
Tumori; 2015; 101(5):542-8. PubMed ID: 25953448
[TBL] [Abstract][Full Text] [Related]
39. Collagen Type III Alpha 1 chain regulated by GATA-Binding Protein 6 affects Type II IFN response and propanoate metabolism in the recurrence of lower grade glioma.
Huang R; Li Z; Zhu X; Yan P; Song D; Yin H; Hu P; Lin R; Wu S; Meng T; Zhang J; Huang Z
J Cell Mol Med; 2020 Sep; 24(18):10803-10815. PubMed ID: 32757451
[TBL] [Abstract][Full Text] [Related]
40. Weighted correlation network analysis identifies multiple susceptibility loci for low-grade glioma.
Niu X; Pan Q; Zhang Q; Wang X; Liu Y; Li Y; Zhang Y; Yang Y; Mao Q
Cancer Med; 2023 Mar; 12(5):6379-6387. PubMed ID: 36305248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
